D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.91%6.19B | -5.05%1.78B | -3.23%1.62B | 5.07%1.4B | 1.74%1.4B | -24.86%6.25B | -22.40%1.87B | -30.49%1.67B | -12.23%1.33B | -30.71%1.37B |
Cost of revenue | -1.78%4.5B | -5.11%1.32B | -5.16%1.13B | 7.80%1B | -2.00%1.05B | -25.55%4.59B | -28.88%1.39B | -31.99%1.19B | -8.99%929.61M | -24.95%1.08B |
Gross profit | 1.46%1.69B | -4.85%458.61M | 1.51%490.59M | -1.25%396.99M | 15.26%342.79M | -22.90%1.66B | 5.36%481.97M | -26.50%483.27M | -18.90%402.01M | -45.77%297.42M |
Operating expense | 6.17%1.4B | 13.73%363.97M | 4.28%352.6M | 4.88%331.85M | 2.12%347.55M | -3.06%1.31B | -8.04%320.02M | -1.77%338.15M | -2.77%316.41M | 0.47%340.33M |
Operating profit | -16.23%293M | -41.56%94.64M | -4.92%137.98M | -23.90%65.15M | 88.90%-4.77M | -56.42%349.77M | 48.00%161.95M | -53.67%145.13M | -49.73%85.61M | -120.47%-42.91M |
Net non-operating interest income (expenses) | 53.63%-3.17M | 60.06%-715K | 51.45%-921K | 22.47%-1.17M | 77.68%-368K | 11.86%-6.85M | -1.82%-1.79M | -3.15%-1.9M | 29.94%-1.51M | 18.16%-1.65M |
Non-operating interest income | 10,757.89%2.06M | 3,712.50%305K | 15,150.00%305K | 2,414.29%176K | 63,750.00%1.28M | -59.57%19K | -42.86%8K | -77.78%2K | -53.33%7K | -77.78%2K |
Non-operating interest expense | -23.70%5.24M | -43.27%1.02M | -35.44%1.23M | -11.21%1.35M | -0.36%1.65M | -12.15%6.86M | 1.47%1.8M | 2.76%1.9M | -30.11%1.52M | -18.43%1.65M |
Net investment income | 32.27%37.83M | -35.67%6.04M | 113.64%5.78M | -2.20%9.45M | 141.98%16.56M | 13.93%28.6M | 57.58%9.39M | -44.49%2.71M | 2.36%9.66M | 41.58%6.84M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -14.21M | ||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0.55%33.25M | 96.62%27.77M | -106.05%-360K | -33.94%2.6M | -64.30%3.23M | -21.45%33.06M | 132.09%14.13M | -63.72%5.95M | -71.29%3.94M | 53.41%9.05M |
Less:Other special charges | -39.61%-33.25M | -97.21%-27.77M | --0 | ---3.05M | ---2.42M | 43.43%-23.81M | -119.43%-14.08M | 60.62%-6.5M | ---- | ---- |
Less:Write off | --0 | --0 | -34.55%360K | 163.88%451K | 91.04%-811K | ---9.25M | -112.65%-42K | 409.26%550K | -212.39%-706K | -4,130.37%-9.05M |
Other non-operating income (expenses) | 408.47%37.84M | 67.62%9.6M | 292.12%4.08M | 2,911.76%10.75M | 4,116.04%13.41M | 63.04%7.44M | 68.21%5.73M | 2,022.45%1.04M | -71.53%357K | 322.38%318K |
Income before tax | 0.23%398.74M | -21.61%137.34M | -4.16%146.56M | -11.50%86.78M | 199.03%28.07M | -54.09%397.81M | 42.30%175.19M | -54.04%152.92M | -49.08%98.05M | -112.99%-28.34M |
Income tax | -2.85%113.84M | -7.96%33.2M | 4.63%47.54M | 9.60%16.59M | -19.59%16.51M | -42.70%117.17M | -17.89%36.07M | -26.45%45.43M | -59.74%15.14M | -66.45%20.53M |
Net income | 1.52%284.9M | -25.14%104.14M | -7.88%99.02M | -15.35%70.19M | 123.65%11.56M | -57.61%280.64M | 75.69%139.12M | -60.33%107.49M | -46.49%82.91M | -131.13%-48.88M |
Net income continuous operations | 1.52%284.91M | -25.14%104.14M | -7.88%99.02M | -15.35%70.19M | 123.65%11.56M | -57.61%280.64M | 75.70%139.12M | -60.33%107.49M | -46.49%82.91M | -131.13%-48.88M |
Noncontrolling interests | 258K | 0 | 0 | 0 | 0 | 0 | ||||
Net income attributable to the company | 1.43%284.65M | -25.33%103.88M | -7.88%99.02M | -15.35%70.19M | 123.65%11.56M | -57.61%280.64M | 75.69%139.12M | -60.33%107.49M | -46.49%82.91M | -131.13%-48.88M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 1.43%284.65M | -25.33%103.88M | -7.88%99.02M | -15.35%70.19M | 123.65%11.56M | -57.61%280.64M | 75.69%139.12M | -60.33%107.49M | -46.49%82.91M | -131.13%-48.88M |
Gross dividend payment | ||||||||||
Basic earnings per share | 1.44%156.14 | -25.32%56.98 | -7.85%54.32 | -15.35%38.5 | 123.65%6.34 | -57.61%153.92 | 75.69%76.3 | -60.32%58.95 | -46.48%45.48 | -131.14%-26.81 |
Diluted earnings per share | 1.44%156.14 | -25.32%56.98 | -7.81%54.32 | -15.30%38.4949 | 123.65%6.34 | -57.61%153.92 | 75.78%76.3 | -60.33%58.9216 | -46.49%45.4493 | -131.14%-26.81 |
Dividend per share | 0.00%30 | 0.00%30 | 0 | 0 | 0 | 0.00%30 | 0.00%30 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |